[Conjugated vaccines against Haemophilus influenzae type b].
Rümke
H C
HC
Rijksinstituut voor Volksgezondheid en Milieuhygiëne, Bilthoven.
Poolman
J T
JT
D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002675:Child, Preschool; D004168:Diphtheria Toxoid / Q000627:therapeutic use; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology*; D006801:Humans; D007223:Infant; D008583:Meningitis, Haemophilus / Q000517:prevention & control; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D014614:Vaccines, Synthetic / Q000627:therapeutic use
D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D004168:Diphtheria Toxoid; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; C052180:Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate; C061964:Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine; D011135:Polysaccharides, Bacterial; D014614:Vaccines, Synthetic